Medovex Corp Valuation
| HCYTDelisted Stock | USD 2.21 0.00 0.00% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Medovex Corp secures a last-minute Real Value of $2.1 per share. The latest price of the firm is $2.21. Our model forecasts the value of Medovex Corp from analyzing the firm fundamentals such as Return On Equity of -4.6, shares outstanding of 477.61 K, and Operating Margin of (3.51) % as well as examining its technical indicators and probability of bankruptcy. . In general, most investors recommend acquiring undervalued stocks and selling overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Medovex Corp's price fluctuation is very steady at this time. Calculation of the real value of Medovex Corp is based on 3 months time horizon. Increasing Medovex Corp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Medovex otc stock is determined by what a typical buyer is willing to pay for full or partial control of Medovex Corp. Since Medovex Corp is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medovex OTC Stock. However, Medovex Corp's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.21 | Real 2.1 | Hype 2.21 |
The intrinsic value of Medovex Corp's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Medovex Corp's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Medovex Corp helps investors to forecast how Medovex otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medovex Corp more accurately as focusing exclusively on Medovex Corp's fundamentals will not take into account other important factors: Medovex Corp Total Value Analysis
Medovex Corp is currently anticipated to have valuation of 8.88 M with market capitalization of 1.06 M, debt of 3.88 M, and cash on hands of 45.88 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Medovex Corp fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
8.88 M | 1.06 M | 3.88 M | 45.88 K |
Medovex Corp Investor Information
About 26.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.05. Medovex Corp had not issued any dividends in recent years. The entity had 1:1000 split on the 13th of June 2022. Based on the analysis of Medovex Corp's profitability, liquidity, and operating efficiency, Medovex Corp is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Medovex Corp Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Medovex Corp has an asset utilization ratio of 501.4 percent. This implies that the OTC Stock is making $5.01 for each dollar of assets. An increasing asset utilization means that Medovex Corp is more efficient with each dollar of assets it utilizes for everyday operations.Medovex Corp Ownership Allocation
Medovex Corp holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.Medovex Corp Profitability Analysis
The company reported the previous year's revenue of 1.61 M. Net Loss for the year was (4.8 M) with profit before overhead, payroll, taxes, and interest of 906.81 K.About Medovex Corp Valuation
The otc valuation mechanism determines Medovex Corp's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Medovex Corp based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Medovex Corp. We calculate exposure to Medovex Corp's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Medovex Corp's related companies.H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. H CYTE operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 8 people.
8 Steps to conduct Medovex Corp's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Medovex Corp's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Medovex Corp's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Medovex Corp's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Medovex Corp's revenue streams: Identify Medovex Corp's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Medovex Corp's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Medovex Corp's growth potential: Evaluate Medovex Corp's management, business model, and growth potential.
- Determine Medovex Corp's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Medovex Corp's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Medovex Corp Growth Indicators
Investing in growth stocks can be very risky. If the company such as Medovex Corp does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 164.2 M | |
| Retained Earnings | -49 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Medovex OTC Stock
If you are still planning to invest in Medovex Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medovex Corp's history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Commodity Directory Find actively traded commodities issued by global exchanges |